Skip to main content

Correction: Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)

The Original Article was published on 22 October 2020

Correction: BMC Primary Care 21, 215 (2020)

https://doi.org/10.1186/s12875-020-01283-x

Following publication of the original article [1], the authors identified some errors in the published equation on Table 2, the published Fig. 3 (the estimated odds and likelihood ratio were incorrect due to our mistake in specifying the equation within the calculator), and the discussion part (related to the figure) in the manuscript. The correction details are stated as follows:

  1. 1)

    Log (Log globulin) of the 4th entry under Formula column should not be superscripted.

Table 2 Multivariable fractional polynomial logistic regression model for diagnostic prediction of multiple myeloma. (imputed dataset with a total n = 586)
  1. 2)

    Our previous equation embedded within the online web calculator was incorrect. After correction, the model estimated the predicted odds of MM at 0.436 with a positive likelihood ratio of 1.429 (suspected MM) (Fig. 3). Figure 3 was corrected accordingly. The suggestion in the following sentence was also corrected to follow the model’s estimates. The 9th and 10th sentence of the 3rd paragraph on page 9 should read:

The model predicted the odds of MM at 0.436 with a positive likelihood ratio of 1.429 (suspected MM) (Fig. 3). Based on that, this patient should have been considered for referral to a hematologist for further work-up and a definitive diagnosis.

Fig. 3
figure 1

The web application interface of the MM-BM DDx model. Three clinical laboratory parameters can be used for prediction of the presence of multiple myeloma

Reference

  1. Phinyo P, Maihom T, Phanphaisarn A, et al. Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx). BMC Fam Pract. 2020;21:215. https://doi.org/10.1186/s12875-020-01283-x.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dumnoensun Pruksakorn.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Phinyo, P., Maihom, T., Phanphaisarn, A. et al. Correction: Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx). BMC Prim. Care 23, 189 (2022). https://doi.org/10.1186/s12875-022-01785-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12875-022-01785-w